Lewis, K., Peris, K., Sekulic, A., Stratigos, A., Dunn, L., Eroglu, Z., Chang, A.L., Migden, M., Li, S., Yoo, S.-Y., Mohan, K., Coates, E., Okoye, E., Baurain, J.-F., Bechter, O., Hauschild, A., Butler, M., Hernandez-Aya, L., Licitra, L., Neves, R., Ruiz, E., Seebach, F., Lowy, I., Bowler, T. and Fury, M. 2021. Interim Analysis of Phase 2 Results for Cemiplimab in Patients with Metastatic Basal Cell Carcinoma (mBCC) who Progressed on or are Intolerant to Hedgehog Inhibitors (HHIs). SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s3. DOI:https://doi.org/10.25251/skin.5.supp.3.